# Levosimendan Versus Dobutamine in Shock Patients

> **NCT00093301** · PHASE2,PHASE3 · UNKNOWN · sponsor: **Wentworth Area Health Services** · enrollment: 40 (—)

## Conditions studied

- Cardiogenic Shock
- Septic Shock

## Interventions

- **DRUG:** Levosimendan
- **DRUG:** Dobutamine

## Key facts

- **NCT ID:** NCT00093301
- **Lead sponsor:** Wentworth Area Health Services
- **Sponsor class:** OTHER
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2004-10
- **Primary completion:** —
- **Final completion:** 2006-04
- **Target enrollment:** 40 (—)
- **Last updated:** 2005-06-24

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00093301

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00093301, "Levosimendan Versus Dobutamine in Shock Patients". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT00093301. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*